Tocilizumab as treatment for COVID-19: A systematic review and meta-analysis.

World J Methodol · 2021 · PMC8127418 · PMID 34026583

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a strong trendno p-value reported

In this pooled analysis of 31 studies including 2898 patients treated with TCZ, we found a strong trend toward improved survival with the use of TCZ (a significant reduction in acute mortality risk by 36%).

also in 5,725 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.